/FDMDF
FDMDF Stock - 4DMedical Limited
Healthcare|Medical - DevicesOTC
$2.35+27.03%
+$0.50 (+27.03%) • Dec 19
63
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.100
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.15
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $2.59
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for FDMDF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.33 – $2.37
TARGET (TP)$2.70
STOP LOSS$2.16
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.61
52W High$2.35
52W Low$0.16
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.85M | $3.05M | $718,581 | $1.05M | $216,978 |
| Gross Profit | $5.39M | $2.81M | $-24,277,649 | $280,617 | $125,125 |
| Gross Margin | 92.1% | 92.2% | -3378.6% | 26.6% | 57.7% |
| Operating Income | $-29,220,394 | $-46,609,656 | $-30,653,334 | $-22,201,017 | $-13,693,892 |
| Net Income | $-30,069,854 | $-35,978,672 | $-31,459,798 | $-24,592,876 | $-21,420,531 |
| Net Margin | -513.7% | -1179.8% | -4378.0% | -2332.6% | -9872.2% |
| EPS | $-0.07 | $-0.11 | $-0.10 | $-0.08 | $-0.08 |
Company Overview
4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator. The company was incorporated in 2012 and is based in Carlton, Australia.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
FDMDFBeat Rate
100%
Last 1 quarters
Avg Surprise
+37.5%
EPS vs Estimate
Beats / Misses
1/0
Last 12 quarters
Latest EPS
$-0.03
Q3 2025
EPS Surprise History
Q1 22
No data
Q3 22
No data
Q1 23
No data
Q2 23
No data
Q2 24
No data
Q3 24
No data
Q1 25
+37.5%
$-0.02vs$-0.02
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 2, 2026 | — | — | — | — |
Q3 2025 | Sep 1, 2025 | — | $-0.03 | — | — |
Q1 2025 | Mar 3, 2025 | $-0.02 | $-0.02 | +37.5% | ✓ BEAT |
Q3 2024 | Sep 29, 2024 | — | $-0.05 | — | — |
Q2 2024 | May 10, 2024 | — | $-0.03 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.03 | — | — |
Q1 2023 | Feb 27, 2023 | — | $-0.04 | — | — |
Q3 2022 | Aug 18, 2022 | — | $-0.03 | — | — |
Q1 2022 | Feb 27, 2022 | — | $-0.03 | — | — |
Q3 2021 | Aug 23, 2021 | — | $-0.02 | — | — |
Q1 2021 | Feb 24, 2021 | — | $-0.04 | — | — |
Q3 2020 | Aug 28, 2020 | — | $-0.04 | — | — |
Q4 2019 | Dec 30, 2019 | — | $-0.01 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.02 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.01 | — | — |
Q2 2018 | Jun 29, 2018 | — | $-0.01 | — | — |
Q4 2017 | Dec 30, 2017 | — | $-0.01 | — | — |
Q2 2017 | Jun 29, 2017 | — | $-0.01 | — | — |
Q4 2016 | Dec 30, 2016 | — | $-0.01 | — | — |
Q4 2015 | Dec 31, 2015 | — | $-11.94 | — | — |
Latest News
Loading news...
Frequently Asked Questions about FDMDF
What is FDMDF's current stock price?
4DMedical Limited (FDMDF) is currently trading at $2.35 per share. The stock has moved +27.03% today.
What is the analyst price target for FDMDF?
No analyst price targets are currently available for this stock.
What sector is 4DMedical Limited in?
4DMedical Limited operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is FDMDF's market cap?
4DMedical Limited has a market capitalization of $1.23 billion, making it a small-cap company.
Does FDMDF pay dividends?
No, 4DMedical Limited does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAGYTF
Allergy Therapeutics plc
$0.11
Mkt Cap: $0.5B
BJTRF
Beijing Tong Ren Tang Chinese Medicine Company Limited
$0.65
Mkt Cap: $0.5B
CALZF
PolyNovo Limited
$0.74
Mkt Cap: $0.5B
CLVSF
CellaVision AB (publ)
$16.83
Mkt Cap: $0.4B
FOGCF
Avisa Diagnostics Inc.
$0.00
Mkt Cap: $0.0B
GSGTF
GenSight Biologics S.A.
$0.19
Mkt Cap: $0.0B
LBLTF
Lattice Biologics Ltd.
$0.00
Mkt Cap: $0.0B
MNFSF
ManifestSeven Holdings Corporation
$0.00
Mkt Cap: $0.0B
SOLTF
Nxera Pharma Co., Ltd.
$5.34
Mkt Cap: $0.5B
XVIPF
Xvivo Perfusion AB (publ)
$19.40
Mkt Cap: $0.6B
Explore stocks similar to FDMDF for comparison